These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8757017)

  • 21. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
    Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
    Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
    Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
    Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE; Tanzi RE
    Neurology; 1995 Jul; 45(7):1323-8. PubMed ID: 7617191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
    González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
    Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.
    Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Edwardson JA; Torvik A; Morris CM; Bjertness E
    Neurodegeneration; 1996 Mar; 5(1):43-7. PubMed ID: 8731381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
    Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
    Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.
    Frisoni GB; Govoni S; Geroldi C; Bianchetti A; Calabresi L; Franceschini G; Trabucchi M
    Ann Neurol; 1995 May; 37(5):596-604. PubMed ID: 7755354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
    Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
    Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism and Alzheimer's disease.
    Yen YC; Liu CK; Lung FW; Chong MY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):190-7. PubMed ID: 11482130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.
    Lucotte G; Visvikis S; Leininger-Müler B; David F; Berriche S; Réveilleau S; Couderc R; Babron MC; Aguillon D; Siest G
    Am J Med Genet; 1994 Sep; 54(3):286-8. PubMed ID: 7810590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
    Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
    Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
    Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P
    Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
    Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
    Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.
    Corder EH; Jelic V; Basun H; Lannfelt L; Valind S; Winblad B; Nordberg A
    Arch Neurol; 1997 Mar; 54(3):273-7. PubMed ID: 9074396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.